NYSE · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · LARGE CAP
Integer Holdings Corporation ITGR
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.9B
▲ 8.0% vs FY2024
EPS · FY25
$2.89
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
6.1%
Net margin · FY25
5.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.9B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 2.89
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
6.1%
Return on equity, FY2025
ROE
Operating margin11.9%
Net margin5.5%
Return on assets3.2%
Each USD of equity produced 6 cents of profit this year.
Returned to shareholders
USD 46.4M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 46.4M
Share of profit45.1%
Consecutive raises—
USD 46.4M in buybacks — 45% of the year's profit went back to shareholders.
Growth
+11.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+11.7%
+11.5%
+8.8%
+8.7%
Net income
+15.7%
+5.9%
+7.8%
EPS, diluted
+13.2%
+4.4%
+5.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years+4.4%
Change, 10 years+12.2%
The share count grew 4% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.4B
total assets, end of FY2025
Total assetsUSD 3.4B
EquityUSD 1.7B
CashUSD 17.2M
Gross debtUSD 1.2B
Net debtUSD 1.2B
Current ratio3.32×
Net debt stands at 67% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
1.9
1.7
1.6
1.3
1.2
1.1
1.3
1.2
1.1
1.1
0.8
0.7
0.7
0.6
0.6
0.5
0.5
Operating income $B
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.0
EBITDA $B
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
Net income $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0
−0.0
0.1
0.0
−0.0
0.0
0.0
−0.0
EPS, diluted $
2.89
3.36
2.69
1.99
2.91
2.33
2.92
5.15
2.08
0.19
−0.29
2.14
1.43
−0.20
1.40
1.40
−0.39
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
6.1
7.6
6.2
4.8
7.4
6.4
8.7
17.2
8.2
0.8
−1.0
9.6
7.1
−1.0
7.4
8.2
−2.4
Shares out B
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed